Login / Signup
Yuchen Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 4
Top Topics
Double Blind
Study Protocol
Nk Cells
Cancer Therapy
Top Venues
Journal of hematology & oncology
ImmunoTargets and therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yuchen Li
,
Yinfeng Gu
,
Pengyue Yang
,
Yan Wang
,
Xibao Yu
,
Yangqiu Li
,
Zhenyi Jin
,
Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.
ImmunoTargets and therapy
13 (2024)
Yuchen Li
,
Yinfeng Gu
,
Pengyue Yang
,
Yan Wang
,
Xibao Yu
,
Yangqiu Li
,
Zhenyi Jin
,
Ling Xu
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.
ImmunoTargets and therapy
13 (2024)
Letong Cai
,
Yuchen Li
,
Jiaxiong Tan
,
Ling Xu
,
Yangqiu Li
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
Journal of hematology & oncology
16 (1) (2023)
Letong Cai
,
Yuchen Li
,
Jiaxiong Tan
,
Ling Xu
,
Yangqiu Li
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
Journal of hematology & oncology
16 (1) (2023)